Sophia Delicou: Bronze Award for Hippokration’s Hemoglobinopathy Centre
Sophia Delicou, Head of Thalassemia and Sickle Cell Unit, Head of the Expertise Center of Hemoglobin Diseases and Their Complications at Hippokrateio General Hospital, shared a post on LinkedIn:
“Another Prestigious Recognition for the Hemoglobinopathies Expertise Centre of Hippokration General Hospital of Athens Healthcare Awards 2026
We are delighted and proud to announce that, for yet another consecutive year, the Expertise Centre for Hemoglobinopathies and Their Complications at Hippokration General Hospital of Athens has been recognised at the Healthcare Awards 2026, receiving the bronze award!
This latest distinction reflects our Centre’s ongoing commitment to scientific excellence, continuous medical education, international collaboration, and the continuous improvement of specialised, high-quality, patient-centred care for individuals living with hemoglobinopathies.
The award was presented in the category ‘Medical Training and Continuing Medical Education (CME) Programme’ for the initiative:
‘Georgios Tolis Scholarship – Thalassaemia International Federation: Patient-Centred Holistic Medical Education.’
This initiative highlights the importance of our collaboration with the Thalassaemia International Federation (TIF) and our shared commitment to advancing specialised medical knowledge, professional development, and comprehensive, patient-centred healthcare.
Being recognised once again among the award-winning healthcare institutions is a meaningful acknowledgment of our team’s sustained efforts, dedication, scientific expertise, and collective commitment to excellence.
This achievement belongs to everyone who contributes to the Centre’s mission and daily work. It also serves as renewed motivation to continue developing initiatives that advance education, strengthen international cooperation, and ultimately improve the lives of people affected by hemoglobinopathies.
Each recognition is not only a celebration of what we have achieved, but also a commitment to what lies ahead.
We remain dedicated to advancing knowledge, fostering collaboration, and keeping patients at the heart of everything we do.”
Stay updated with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery